Содержание
- 2. Pneumonia - D efinition Pneumonia is an abnormal inflammatory condition of the lung. It is often
- 3. Community Acquired Pn eu monia Definition: Acute infection of the pulmonary parenchyma that is associated with
- 4. Community-Acquired Pneum onia ( CAP ) ■ Community-acquired ■ pneumonia refers to pneumonia acquired outside of
- 5. Why Community Acquired Pneumonia is a Important disease
- 6. changes in CAP causes major the Functional phy siology of the Respiratory tract
- 7. Who Develops Community Acquire d Pneumonia Community-acquired pneumonia develops in people with limited or no contact
- 8. Risk Factors for pneumonia age alcoholism smoking asthma Immuno suppression institutionalization COPD dementia Community Acquired Pneumonia
- 9. Community acquired pneumonia Emerging Health Problem Causes of CAP - Bacteria, viruses, fungi, and parasites. CAP
- 10. Several Microbes can cause CAP ■ The most commonly identified pathogens are Streptococcus pneumoniae, Haemophilus influenzae,
- 11. Typical x Atypical etiological agents Typical pneumonia usually is caused by bacteria such as Streptococcus pneumoniae.
- 12. X ray chest gives the leading clues in Diagnosis
- 13. Pathophysiology CAP is usually acquired via inhalation or aspiration of pulmonary pathogenic organisms into a lung
- 14. Etiological agents in Community-Acquired Pneumonia in Children From Bi rth to 3 weeks Group B streptococci,
- 15. From 3 weeks to 3 months Streptococcus pneumoniae, viruses (RSV, Parainfluenza viruses, metapneumovirus), Bordetella pertussis, Staphylococcus
- 16. From 4 months to 4 years S. pneumoniae, viruses (RSV, Parainfluenza viruses, influenza viruses, adenovirus, rhinovirus,
- 17. 5 years to 15 years S. pneumoniae, M. pneumoniae, and Chlamydia pneumoniae
- 18. COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS
- 19. Outpatients—with no modifying factors present ■ Streptococcus ■ ■ ■ ■ pneumoniae, Mycoplasma pneumoniae, Chlamydia pneumoniae,
- 20. Outpatients—modifying factors present ■ S. pneumoniae, including drug resistant forms; M. pneumoniae; C. pneumoniae; mixed infection
- 21. CAP in Inpatients not admitted in ICU S. pneumoniae, H. influenzae; C.Pneumonia; C. pneumoniae; mixed infection
- 22. Non-bacterial pathogens causing CAP ■ Non bacterial pathogens in the differential include many viruses (influenza, adenovirus,
- 23. Value of chest x-ray in Diag nosis of CAP A chest x-ray is recommended to make
- 24. Microbiological Diagnosis
- 25. Common Laboratory Tests ■ Common laboratory tests for pneumonia have included leukocyte count, sputum Gram stain,
- 26. Microbiological diagnosis is co nfirmatory ■ Is not possible to distinguish the causative organisms of pneumonia
- 27. Bacteriological Investigations o n sputum Expectorated sputum collected ( poorly collected) without proper instructions may not
- 28. Sputum gram staining and culture A good quality sputum sample with a predominant pus cells with
- 29. Newer methods – Diagnosis of Community associated Pneumonias Antigen detestation in sputum urine by Fluorescent methods
- 30. Diagnosis in cases of Atypical P neumonias By serological methods using acute and convalescent sera Raise
- 31. Other markers suggestive of CAP C - reactive protein trends have been correlated to clinical progress
- 32. Pencillin still continues to be preferr ed antibiotic ■ With a bloodstream or lung infection, you
- 33. Antimicrobial therapy – Empiri ca approach Antimicrobial therapy is the mainstay of management for community-acquired pneumonia
- 34. MRSA – a concern in treating Community acquired Pneumonias The worldwide emergence of community-acquired Methicillin- resistant
- 35. Vaccination in children Vaccination is important in both children and adults. Vaccinations against Haemophilus influenzae and
- 36. Community Acquired Pneumonia and Vaccination for Pneumococcal infect ion ✔ The pneumococcal vaccine (the ‘pneumonia shot’)
- 37. Preventing Inf uenzae According to the U.S. ■ Centers for Disease Control and Prevention (CDC), anyone
- 38. General Health Measures Smoking cessation is important not only for treatment of any underlying lung disease,
- 39. Future goals on reducing child deaths – by Hand washing ■ Handwashing with soap is among
- 41. Скачать презентацию






































Клинико-лабораторные аспекты сахарного диабета
Diseases transmitted from animals to humans. Zoonoses
Туберкулез
Кишечная непроходимость
Генетические аспекты кариеса
Системные васкулиты
Презентация (2)
Острая массивная кровопотеря (ОМК)
Лептоспироз
Клинические аспекты применения современных антидепрессантов в психиатрической практике
Общий подход к заболеваниям сердца
Отравление рыбой
Автомобильная травма
Острая дыхательная недостаточность (ОДН)
Лучевая диагностика опорно - двигательной системы. Повреждения костей и суставов (перелом, вывих)
Факторы мутагенеза. Хромосомные болезни-мутации
Атеросклероз
Mite agent demodicosis
Современные методы лабораторной диагностики инфекционных заболеваний
Первая помощь при кровотечениях
Потребности людей с нарушениями опорно-двигательного аппарата и правила корректного общения с ними. Тема 1
Острый тонзиллофарингит
ЧУЗ Медико-санитарная часть. Клиника высокотехнологичной медицины на службе вашего здоровья
Профилактика COVID-19: вакцинация
Экспериментальная апробация отечественного перфторорганического соединения на основе перфтор-1,3-диметилциклогексана
Жизненный цикл ВИЧ
Junctional Emergency Treatment Tool
Консервативное лечение тромбофлебита